دورية أكاديمية
Restaging magnetic resonance imaging of the rectum after neoadjuvant therapy: a practical guide.
| العنوان: | Restaging magnetic resonance imaging of the rectum after neoadjuvant therapy: a practical guide. |
|---|---|
| المؤلفون: | Horvat N; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil., Miranda J; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil., Kinochita F; Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil., de Carvalho TL; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Torri GB; Department of Radiology and Diagnostic Imaging, Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brazil., Lopes TJP; Department of Radiology, Hospital Sírio-Libanês, São Paulo, SP, Brazil., Nomura CH; Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil.; Department of Radiology, Hospital Sírio-Libanês, São Paulo, SP, Brazil. |
| المصدر: | Radiologia brasileira [Radiol Bras] 2024 Jul 16; Vol. 57, pp. e20240004. Date of Electronic Publication: 2024 Jul 16 (Print Publication: 2024). |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Colegio Brasileiro De Radiologia Country of Publication: Brazil NLM ID: 1305000 Publication Model: eCollection Cited Medium: Print ISSN: 0100-3984 (Print) Linking ISSN: 01003984 NLM ISO Abbreviation: Radiol Bras Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Rio De Janeiro : Colegio Brasileiro De Radiologia |
| مستخلص: | Colorectal cancer is the third most common cancer and the second leading cause of cancer-related death. Rectal cancer accounts for approximately one-third of new colorectal cancer cases, with adenocarcinoma as the predominant subtype. Despite an overall decline in colorectal cancer incidence and mortality, due to advancements in screening, early diagnosis, and treatment options, there is a concerning increase in incidence rates among young patients. Recent significant advances in managing locally advanced rectal cancer, such as the establishment of different surgical approaches, neoadjuvant treatment using different protocols for high-risk cases, and the adoption of organ-preservation strategies, have increased the importance of the role played by radiologists in locoregional assessment on magnetic resonance imaging at baseline, at restaging, and during active surveillance of patients with rectal cancer. In this article, we review the role of restaging rectal magnetic resonance imaging after neoadjuvant therapy, providing radiologists with a practical, step-by-step guide for assessing treatment response. |
| References: | Ann Surg Oncol. 2011 Aug;18(8):2224-31. (PMID: 21347783) Dis Colon Rectum. 2018 Mar;61(3):328-337. (PMID: 29369900) Abdom Radiol (NY). 2019 Nov;44(11):3569-3580. (PMID: 30993392) Radiology. 2023 Aug;308(2):e230079. (PMID: 37581503) Radiographics. 2019 Mar-Apr;39(2):367-387. (PMID: 30768361) J Natl Compr Canc Netw. 2021 Aug 17;19(11):1232-1240. (PMID: 34404028) Radiology. 2009 Jul;252(1):71-80. (PMID: 19403847) Radiology. 2009 Jul;252(1):81-91. (PMID: 19403848) Eur Radiol. 2013 Dec;23(12):3440-9. (PMID: 23832319) Abdom Radiol (NY). 2023 Sep;48(9):2771-2791. (PMID: 36899281) J Clin Oncol. 2023 Oct 10;41(29):4643-4651. (PMID: 37478389) Eur Radiol. 2020 Apr;30(4):2312-2323. (PMID: 31953656) Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1018-25. (PMID: 19647949) Adv Surg. 2021 Sep;55:89-107. (PMID: 34389102) Lancet. 1986 Jun 28;1(8496):1479-82. (PMID: 2425199) Clin Radiol. 2016 Sep;71(9):854-62. (PMID: 27381221) Eur Radiol. 2022 Jul;32(7):4991-5003. (PMID: 35254485) J Clin Oncol. 2022 Aug 10;40(23):2546-2556. (PMID: 35483010) Eur J Radiol Open. 2020 Feb 25;7:100223. (PMID: 32140502) BMC Cancer. 2015 Oct 23;15:767. (PMID: 26497495) J Clin Oncol. 2014 May 20;32(15):1554-62. (PMID: 24752056) CA Cancer J Clin. 2021 May;71(3):209-249. (PMID: 33538338) Lancet Gastroenterol Hepatol. 2019 Jul;4(7):511-518. (PMID: 31105047) Radiology. 2009 Oct;253(1):116-25. (PMID: 19789256) Int J Cancer. 2022 Jul 1;151(1):120-127. (PMID: 35191540) Eur J Radiol. 2018 Feb;99:131-137. (PMID: 29362144) JAMA Netw Open. 2020 Dec 1;3(12):e2030097. (PMID: 33326026) Br J Cancer. 2017 Nov 7;117(10):1478-1485. (PMID: 28934761) Nat Rev Clin Oncol. 2021 Dec;18(12):805-816. (PMID: 34349247) Dis Colon Rectum. 2017 Mar;60(3):274-283. (PMID: 28177989) Clin Colorectal Cancer. 2019 Mar;18(1):e87-e95. (PMID: 30420120) AJR Am J Roentgenol. 2023 Aug;221(2):206-216. (PMID: 36919880) Ann Surg. 2004 Oct;240(4):711-7; discussion 717-8. (PMID: 15383798) Lancet Oncol. 2010 Sep;11(9):835-44. (PMID: 20692872) J Natl Compr Canc Netw. 2022 Oct;20(10):1139-1167. (PMID: 36240850) Ann Surg Oncol. 2012 Sep;19(9):2842-52. (PMID: 22526897) Abdom Radiol (NY). 2023 Sep;48(9):2792-2806. (PMID: 37145311) Radiology. 2011 Sep;260(3):771-80. (PMID: 21846762) J Magn Reson Imaging. 2023 Feb;57(2):353-369. (PMID: 36073323) Br J Radiol. 2012 May;85(1013):577-86. (PMID: 21343320) J Clin Oncol. 2024 Feb 10;42(5):500-506. (PMID: 37883738) N Engl J Med. 2022 Jun 23;386(25):2363-2376. (PMID: 35660797) Eur Radiol. 2018 Apr;28(4):1465-1475. (PMID: 29043428) J Clin Oncol. 2011 Oct 1;29(28):3753-60. (PMID: 21876084) Abdom Radiol (NY). 2023 Jun;48(6):1911-1920. (PMID: 37004557) |
| فهرسة مساهمة: | Keywords: Magnetic resonance imaging; Neoadjuvant therapy; Rectal neoplasms; Treatment outcome Local Abstract: [Publisher, Portuguese] O câncer colorretal é o terceiro câncer mais comum e a segunda principal causa de morte relacionada ao câncer. O câncer retal representa aproximadamente um terço dos novos casos de câncer colorretal, sendo o adenocarcinoma o subtipo predominante. Apesar de uma diminuição geral na incidência e mortalidade, impulsionada por avanços na prevenção do câncer, diagnóstico precoce e opções de tratamento aprimoradas, há uma preocupante elevação nas taxas entre os pacientes jovens. Avanços recentes significativos no manejo do câncer retal localmente avançado, como abordagens cirúrgicas, o uso de diferentes protocolos de tratamento neoadjuvante para casos de alto risco e a adoção de estratégias de preservação de órgãos, aumentaram o papel dos radiologistas na avaliação locorregional por meio da ressonância magnética na avaliação inicial, reestadiamento e vigilância ativa de pacientes com câncer retal. Este manuscrito tem como objetivo revisar o papel da ressonância magnética retal no reestadiamento após terapia neoadjuvante, fornecendo aos radiologistas um guia prático para revisar exames nesse contexto. |
| تواريخ الأحداث: | Date Created: 20240725 Latest Revision: 20240726 |
| رمز التحديث: | 20240726 |
| مُعرف محوري في PubMed: | PMC11268099 |
| DOI: | 10.1590/0100-3984.2024.0004 |
| PMID: | 39050261 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 0100-3984 |
|---|---|
| DOI: | 10.1590/0100-3984.2024.0004 |